[关键词]
[摘要]
目的 基于超高效液相色谱-四极杆-飞行时间质谱(ultra-performance liquid chromatography quadrupole time-of-flight tandem mass spectrometry,UPLC-Q-TOF-MS/MS)移行成分及谱效关联探究舒心口服液抗凝血物质基础。方法 采用HPLC建立15批次舒心口服液指纹图谱,以凝血酶时间(thrombin time,TT)为抗凝血活性评价指标,采用灰色关联度及偏最小二乘法建立谱效关系,筛选与药效显著相关的成分;利用UPLC-Q-TOF-MS/MS技术对舒心口服液入血成分进行分析,结合谱效关系筛选出的药效相关成分确定核心活性成分;利用等体积替代策略对核心活性成分进行体外抗凝活性验证。结果 建立了15批次舒心口服液指纹图谱,共标定12个共有峰,经对照品指认出11个化学成分,其中木犀草素、藁本内酯、新绿原酸、羟基红花黄色素A、隐绿原酸、咖啡酸6个成分与TT值的关联性及显著性良好;入血成分分析共鉴定66个入血原型成分,主要类型为黄酮类、酚酸类、苯丙素类;其中新绿原酸、咖啡酸、羟基红花黄色素A、木犀草素为体外谱效体内入血的交集成分,确定以上4个成分为舒心口服液的抗凝血物质基础。活性验证结果显示,复方稀释基准组有明显抗凝血活性,4种活性成分-纯化水配比组与空白对照组比无显著抗凝活性(P>0.05),但活性成分-舒心口服液配比组与空白对照组及复方稀释基准组均有显著性差异(P<0.01)。结论 构建了舒心口服液指纹图谱及体外抗凝血活性谱效关系,明确了其入血成分,阐明了其抗凝血物质基础,证实了新绿原酸、咖啡酸、羟基红花黄色素A、木犀草素作为舒心口服液物质基础与复方其他背景成分协同增效发挥抗凝血作用的可靠性。为进一步临床研究提供了科学依据,也为中药复方药效物质基础研究提供了新策略。
[Key word]
[Abstract]
Objective To investigate the anticoagulant substance basis of Shuxin Oral Liquid by analyzing its migration components and spectrum-effect relationships using ultra-performance liquid chromatography quadrupole time-of-flight tandem mass spectrometry (UPLC-Q-TOF-MS/MS). Methods High-performance liquid chromatography (HPLC) was employed to establish fingerprint profiles for 15 batches of Shuxin Oral Liquid, with the anticoagulant activity thrombin time (TT) as the pharmacodynamic indicator. A spectrum-effect relationship was established using grey relational analysis and partial least squares method to identify components significantly associated with pharmacodynamics. UPLC-Q-TOF-MS/MS was utilized to analyze blood-entering components of Shuxin Oral Liquid, and core active ingredients were determined based on the screened pharmacodynamically relevant components. In vitro anticoagulant activity of these core active ingredients was validated using the equal volume substitution strategy. Results Fingerprint profiles for all 15 batches were established, with 12 common peaks identified. Among these, 11 chemical components were confirmed via reference standards, including luteolin, ligustilide, neochlorogenic acid, hydroxysafflor yellow A, cryptochlorogenic acid and caffeic acid, which demonstrated strong correlation and statistical significance with TT value. Blood-entering components analysis identified 66 prototype blood-entering constituents, primarily belonging to flavonoids, phenolic acids and phenylpropanoids. Neochlorogenic acid, caffeic acid, hydroxysafflor yellow A and luteolin were confirmed as integrated components bridging in vitro spectrum-effect profiles and in vivo blood-entry characteristics, thus establishing these four compounds as the fundamental anticoagulant substances of Shuxin Oral Liquid. Activity validation results demonstrated that the compound dilution reference group exhibited significant anticoagulant activity; the ratios of the four active ingredients to purified water showed no significant anticoagulant activity compared to the blank control group (P > 0.05), whereas the ratios of the active ingredients to Shuxin Oral Liquid exhibited significant differences compared to both the blank control group and the compound dilution reference group (P < 0.01). Conclusion The fingerprint profile of Shuxin Oral Liquid and its in vitro anticoagulant activity-response relationship were established; its active components entering the bloodstream were identified; its anticoagulant substance basis was elucidated; and the reliability of neochlorogenic acid, caffeic acid, hydroxysafflor yellow A and luteolin serving as the fundamental components of Shuxin Oral Liquid working synergistically with other background constituents of the compound prescription. These findings provide a scientific basis for further clinical research and offer new strategies for studying the pharmacological substance basis of traditional Chinese medicine formulations.
[中图分类号]
R284.1
[基金项目]
2025年四川省中医药科研专项科技成果转化引导项目(25CGZHZX069); 成都大学2026年省级大学生创业训练计划项目(S202611079005S)